Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Antigen clearance during treatment of disseminated histoplasmosis with itraconazole versus fluconazole in patients with AIDS.

Wheat LJ, Connolly P, Haddad N, Le Monte A, Brizendine E, Hafner R.

Antimicrob Agents Chemother. 2002 Jan;46(1):248-50.

2.

Clearance of fungal burden during treatment of disseminated histoplasmosis with liposomal amphotericin B versus itraconazole.

Wheat LJ, Cloud G, Johnson PC, Connolly P, Goldman M, Le Monte A, Fuller DE, Davis TE, Hafner R; AIDS Clinical Trials Group; Mycoses Study Group of NIAID.

Antimicrob Agents Chemother. 2001 Aug;45(8):2354-7.

3.

DNA fingerprinting of serial Candida albicans isolates obtained during itraconazole prophylaxis in patients with AIDS.

Le Monte AM, Goldman M, Smedema ML, Connolly PA, McKinsey DS, Cloud GA, Kauffman CA, Wheat LJ; National Institute of Allergy and Infectious Disease Mycoses Study Group.

Med Mycol. 2001 Apr;39(2):207-13.

PMID:
11346270
4.

Hypothesis on the mechanism of resistance to fluconazole in Histoplasma capsulatum.

Wheat J, Marichal P, Vanden Bossche H, Le Monte A, Connolly P.

Antimicrob Agents Chemother. 1997 Feb;41(2):410-4.

Supplemental Content

Loading ...
Support Center